MedPath

clinical efficacy of sitafloxacin( 200mg daily)against female patients with acute cystitis

Not Applicable
Conditions
Acute cystitis
Registration Number
JPRN-UMIN000009852
Lead Sponsor
Jikei university katsushika medical center,Department of urology
Brief Summary

The efficacy of STFX against the female patients with AUC due to E,coli was moderately low in this study.longer regimen of STFX might be necessary for AUC.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patient who has urinary catheter. (2)Patient who has urinary diversion. (3)Patient who has been administered other antibiotics and her symptom has been improved before starting administration of this study. (4)Patient administered sitafloxacin within a week before starting administration of this study. (5)Patient with severe infectious disease, who cannot be expected efficacy of oral antimicrobials therapy. (6)Patient with severe underlying disease or complications, who cannot be evaluated efficacy and safety of this study. (7)Patient with a history of allergies against fluoroquinolone. (8)Patient with severe cardiac or hepatic dysfunction. (9)Patient with moderate renal dysfunction (Criteria: Serum Creatinine >2mg/dL) (10)Patient with convulsive disorders like epilepsy or with a history of these deseases. (11)Pregnant women. (12)Patient disqualified as target by doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath